Inventor · disambiguated record
Xian Zhang
Also filed as: ZHANG XIAN · ZHANG XIAN-FENG
32 granted patents·9 pending applications·92 citations·filing 1993–2024
94Inventor score
Files withUNIV JIANGNAN17GEN HOSPITAL CORP4INST PHARMACOLOGY & TOXICOLOGY ACAD MILITARY MEDICAL SCIENCES PLA CHINA2LI SONG2NANJING SANHOME PHARMACEUTICAL CO LTD2
Top patents by PatentIndex Score
41 records- 0191US10865404B1Aspartase mutant, recombinant expression vector and recombinant bacterium containing aspartase mutant, and use thereofUNIV JIANGNAN·Filed 2020·Granted Dec 15, 2020·6 cites·7 claims
- 0281US9970938B2Use of BUBR1 as a biomarker of drug response to furazanobenzimidazolesBASILEA PHARMACEUTICA AG·Filed 2016·Granted May 15, 2018·2 cites·60 claims
- 0376US5767075AInhibiting protein interactionsGEN HOSPITAL CORP·Filed 1995·Granted Jun 16, 1998·30 cites·12 claims
- 0475US5582995AMethods of screening for compounds which inhibit the direct binding of Ras to RafGEN HOSPITAL CORP·Filed 1993·Granted Dec 10, 1996·24 cites·2 claims
- 0572US9630957B22,3-butanediamide epoxide compound and preparation method and use thereofINST PHARMACOLOGY & TOXICOLOGY ACAD MILITARY MEDICAL SCIENCES PLA CHINA·Filed 2014·Granted Apr 25, 2017·1 cites·14 claims
- 0671US12480112B2Glutamate decarboxylase mutant with improved pH tolerance and use thereof in synthesis of gamma-aminobutyric acidUNIV JIANGNAN·Filed 2023·Granted Nov 25, 2025·0 cites·10 claims
- 0771US10731138B2Formate dehydrogenase mutant with improved enzyme activity and stability and construction method thereofUNIV JIANGNAN·Filed 2016·Granted Aug 4, 2020·1 cites·6 claims
- 0871US5736337AInhibiting protein interactionsGEN HOSPITAL CORP·Filed 1994·Granted Apr 7, 1998·18 cites·18 claims
- 0970US12473528B2Escherichia coli for synthesizing l-valine, construction method and use thereofUNIV JIANGNAN·Filed 2024·Granted Nov 18, 2025·0 cites·5 claims
- 1066US12486498B2L-arginine-glycine amidinotransferase and use thereof in the production of guanidinoacetic acidUNIV JIANGNAN·Filed 2024·Granted Dec 2, 2025·0 cites·1 claims
- 1162US2025152629A1Compositions including killer innate-like t cells and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2023·Application pending·0 cites
- 1262US2024018557A1Recombinant nucleic acid of escherichia coli, recombinant escherichia coli and culturing method thereof, and method for biosynthesizing l-threonine therebyUNIV JIANGNAN·Filed 2022·Application pending·0 cites
- 1360US12383535B2Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method thereforUNIV CHINA PHARMA·Filed 2020·Granted Aug 12, 2025·0 cites·7 claims
- 1460US11203742B2Sucrose phosphorylase mutant with improved enzyme activity and construction method thereof and use thereofUNIV JIANGNAN·Filed 2020·Granted Dec 21, 2021·0 cites·15 claims
- 1560US2025177381A1Medicinal salt of cariprazine and crystal form thereof, pharmaceutical composition thereof, and preparation method therefor and use thereofSHANGHAI YONSUN BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 1658US11001825B2Thermophilic L-asparaginase mutant and screening and fermentation methods thereofUNIV JIANGNAN·Filed 2019·Granted May 11, 2021·0 cites·5 claims
- 1758US9522891B2Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infectionINST PHARMACOLOGY & TOXICOLOGY ACAD MILITARY MEDICAL SCIENCES PLA CHINA·Filed 2014·Granted Dec 20, 2016·0 cites·10 claims
- 1857US11098287B217β-hydroxysteroid dehydrogenase mutants and application thereofUNIV JIANGNAN·Filed 2020·Granted Aug 24, 2021·0 cites·9 claims
- 1957US2024002867A1Bacillus subtilis strain, recombinant bacillus subtilis strain and use thereofUNIV JIANGNAN·Filed 2022·Application pending·0 cites
- 2056US11001871B2Method for producing 9alpha-hydroxy androstane-4-alkene-3,17-diketone by enzymatic conversionUNIV JIANGNAN·Filed 2019·Granted May 11, 2021·0 cites·11 claims
- 2153US11060076B2Method for producing 1,2-amino alcohol compound by whole cell transformationUNIV JIANGNAN·Filed 2019·Granted Jul 13, 2021·0 cites·4 claims
- 2253US8846678B2Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infectionLI SONG·Filed 2011·Granted Sep 30, 2014·0 cites·4 claims
- 2353US5763571AInhibiting protein interactionsGEN HOSPITAL CORP·Filed 1995·Granted Jun 9, 1998·8 cites·21 claims
- 2452US2024148903A1Delivery of antibody by using dual viral vector systemNANJING GENSCRIPT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 2551US10329592B2Signal peptide, L-glutamic acid synthesized using konjac flour and methods of using sameUNIV JIANGNAN·Filed 2015·Granted Jun 25, 2019·0 cites·1 claims
- 2650US10465218B2Method for increasing yield of L-arginine by knocking out Flavin reductasesUNIV JIANGNAN·Filed 2016·Granted Nov 5, 2019·0 cites·10 claims
- 2750US10351816B2Signal peptide, L-glutamic acid synthesized using konjac flour and methods of using sameUNIV JIANGNAN·Filed 2015·Granted Jul 16, 2019·0 cites·1 claims
- 2849US2023355612A1Pharmaceutically acceptable salt of cariprazine and crystal form thereof, and preparation method therefor and use thereofSHANGHAI BOCIMED PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 2948US10920251B2Microbial production of fatsUNIV RICE WILLIAM M·Filed 2017·Granted Feb 16, 2021·0 cites·9 claims
- 3048US2023414504A1Cariprazine pharmaceutical composition, preparation method and application thereofSHANGHAI BOCIMED PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 3144US10851393B2KAS-III free FA synthesisUNIV RICE WILLIAM M·Filed 2016·Granted Dec 1, 2020·0 cites·17 claims
- 3244US10222377B2Use of BUBR1 as a biomarker of drug response to furazanobenzimidazolesLANE HEIDI ALEXANDRA·Filed 2012·Granted Mar 5, 2019·0 cites·61 claims
- 3343US2005064384A1Recruitment of mst1 or mst2 protein kinase to induce apoptosis in eukaryotic cellsFiled 2002·Application pending·0 cites
- 3442US10851352B2Mycobacterium neoaurum-derived steroid C27-monooxygenase and application thereofUNIV JIANGNAN·Filed 2016·Granted Dec 1, 2020·0 cites·3 claims
- 3541US10612054B2Single-cell factory for efficiently synthesizing α-aminobutyric acid and construction and application thereofUNIV JIANGNAN·Filed 2016·Granted Apr 7, 2020·0 cites·14 claims
- 3641US9512108B29,9,10,10-Tetrafluoro-9,10-dihydrophenanthrene hepatitis C virus inhibitor and application thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2014·Granted Dec 6, 2016·0 cites·19 claims
- 3740US9428496B2Thiazolamine derivative and use thereof as anti-picornaviral infection medicamentLI SONG·Filed 2011·Granted Aug 30, 2016·0 cites·3 claims
- 3839US6140488ARas-binding protein (PRE1)Filed 1997·Granted Oct 31, 2000·2 cites·8 claims
- 3938US10125383B2Method for producing L-citrulline by using a recombinant Corynebacterium crenatum strainRAO ZHIMING·Filed 2018·Granted Nov 13, 2018·0 cites·9 claims
- 4037US9963480B2Nucleoside phosphoramidate compound and use thereofNANJING SANHOME PHARMACEUTICAL CO LTD·Filed 2014·Granted May 8, 2018·0 cites·18 claims
- 4137US2020115708A1DNA probe library for hybridization with microsatellite instability related microsatellite loci, detection method and kitGENESEEQ TECH INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xian Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →